A randomized placebo-controlled study on the added value of D-cycloserine to exposure therapy in patients with posttraumatic stress disorder
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Cycloserine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 30 Jul 2012 Status changed from recruiting to completed.
- 01 Jun 2012 Results published in Biological Psychiatry.
- 15 Mar 2012 Planned patient number is 100 according to European Clinical Trials Database.